医療用ポリマーの世界市場：現状分析と予測（2021年～2027年）

世界の医療用ポリマーの市場規模は、予測期間（2021年～2027年）中に約8％のCAGRで成長すると予測されています。老年人口の増加、感染症の蔓延、複雑な外科的治療を必要とする心臓血管系疾患の有病率の上昇は、医療用ポリマー市場の成長を後押ししています。

当レポートでは、世界の医療用ポリマー市場について調査しており、市場の洞察、市場動向、競合シナリオ、企業概要など、包括的な情報を提供しています。

目次

第1章 市場イントロダクション

• 市場の定義
• 制限
• ステークホルダー
• レポートで使用される通貨

第2章 調査方法または仮定

• 医療用ポリマー市場の調査プロセス
• 医療用ポリマー市場の調査手法
• 予測方法
• 回答者プロファイル
• 医療用ポリマー市場調査の主な目的

第3章 市場要約

第4章 エグゼクティブサマリー

第5章 世界の医療用ポリマー市場へのCOVID-19の影響

第6章 世界の医療用ポリマー市場の収益（100万米ドル）（2019年～2027年）

第7章 市場の洞察：タイプ別

• コモディティポリマー
• エンジニアリングポリマー
• 高性能ポリマー

第8章 市場の洞察：組成別

• 結晶性
• 非結晶性

第9章 市場の洞察：用途別

• 医療用使い捨て用品
• 補綴
• 医療機器およびツール
• 薬物送達
• その他

第10章 市場の洞察：地域別

• 北米の医療用ポリマー市場
  • 米国
  • カナダ
  • その他北米
• 欧州の医療用ポリマー市場
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • その他欧州
• アジア太平洋の医療用ポリマー市場
  • 中国
  • 日本
  • インド
  • オーストラリア
  • その他アジア太平洋地域
• その他の世界の医療用ポリマー市場

第11章 医療用ポリマー市場の力学

• 市場促進要因
• 市場の課題
• 影響分析

第12章 医療用ポリマー市場の機会

第13章 医療用ポリマー市場の動向

第14章 法律および規制の枠組み

第15章 需要側と供給側の分析

• 需要側分析
• 供給側分析
  • 主要製品の発売
  • 主要企業パートナーシップ
  • 上位の事業拡大、投資、売却
  • 主要な合併と買収

第16章 バリューチェーン分析

第17章 競合シナリオ

• ポーターのファイブフォース分析
  • 買い手の交渉力
  • サプライヤーの交渉力
  • 競争の激しさ
  • 新規参入者の脅威
  • 代替品の脅威
• 企業シェア分析：収益別

第18章 会社概要

• SABIC
• BASF SE
• Celanese Corporation
• Evonik Industries AG
• Solvay S.A.
• Arkema S.A.
• The Lubrizol Corporation
• The Ensinger Group
• Covestro AG
• Victrex plc

第19章 免責事項

The global medical polymer market is likely to showcase a growth of around 8% during the forecast period. Today, the aging population is rapidly growing all over the world and around two-thirds of cancer occurs mainly in people who are 65 years old or above. With aging, the physiological functions of the body get affected such as impairment of vision and hearing, reduced gastrointestinal motility, kidney function, and reduced cardiovascular function. The rise in the geriatric population coupled with overspreading of infectious diseases, and the rising prevalence of cancer, arthritis, and cardiovascular diseases, which require complex surgical treatments propel the medical polymer market growth. In addition, now, countries are focusing more on improving the healthcare sector, which in turn is likely to fuel the market.

Insights Presented in the Report

"Amongst type, the high-performance polymer segment is likely to showcase substantial growth during the forecast period"

Based on type, the market is categorized into commodity polymer, engineering polymer, and high-performance polymer. Among these, the high-performance polymer is likely to showcase robust growth owing to the increasing adoption of these polymers in prosthetics, medical devices, and drug delivery devices applications due to their resilience against a majority of body substances and are highly heat resistant and inert, thereby which makes them ideal for medical devices that come into direct contact with blood and tissue. 

"Amongst applications, medical disposable segment held a prominent share in the market in 2020"

Based on application, the market is categorized into medical disposables, prosthetics, medical instruments & tools, drug delivery, and others. Among these, medical disposables accounted for a significant share of the market and is likely to showcase considerable growth during the forecast period. Medical disposables are single-use products that are prerequisite supplies before any surgery or procedure. As the cases of chronic diseases are increasing, demand for surgery and other procedure will eventually grow. Thereby, increasing the demand for medical disposables. Further, changing lifestyles of people, demand for better healthcare services, and the growing geriatric population are also contributing to the segment growth.

"North America accounted for a considerable share in the global medical polymer market"

For a better understanding of the market adoption of Medical Polymer, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, Rest of North America), Europe (Germany, UK, France, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America accounted for a prominent share in the medical polymer market on account of the presence of a highly diversified medical devices market and it offers a wide range of products for the diagnosis and treatment of patients, ranging from medical catheters to implants and vascular grafts.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts

• The report presents a quick review of overall industry performance at one glance

• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

• The study comprehensively covers the market across different segments

• Deep dive country-level analysis of the industry

Customization Options:

The global medical polymer market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Limitation
• 1.3. Stake Holders
• 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Medical Polymer Market
• 2.2. Research Methodology of the Medical Polymer Market
• 2.3. Forecasting Method
• 2.4. Respondent Profile
• 2.5. Main Objective of the Medical Polymer Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL MEDICAL POLYMER MARKET COVID-19 IMPACT

6 GLOBAL MEDICAL POLYMER MARKET REVENUE (USD MN), 2019-2027F

7 MARKET INSIGHTS BY TYPE

• 7.1. Commodity Polymer
• 7.2. Engineering Polymer
• 7.3. High-Performance Polymer

8 MARKET INSIGHTS BY STRUCTURE

• 8.1. Crystalline
• 8.2. Amorphous

9 MARKET INSIGHTS BY APPLICATION

• 9.1. Medical Disposables
• 9.2. Prosthetics
• 9.3. Medical Instruments & Tools
• 9.4. Drug Delivery
• 9.5. Others

10 MARKET INSIGHTS BY REGION

• 10.1. North America Medical Polymer Market
  • 10.1.1. United States
  • 10.1.2. Canada
  • 10.1.3. Rest of North America
• 10.2. Europe Medical Polymer Market
  • 10.2.1. Germany
  • 10.2.2. France
  • 10.2.3. United Kingdom
  • 10.2.4. Italy
  • 10.2.5. Spain
  • 10.2.6. Rest of Europe
• 10.3. Asia Pacific Medical Polymer Market
  • 10.3.1. China
  • 10.3.2. Japan
  • 10.3.3. India
  • 10.3.4. Australia
  • 10.3.5. Rest of Asia Pacific
• 10.4. Rest of World Medical Polymer Market

11 MEDICAL POLYMER MARKET DYNAMICS

• 11.1. Market Drivers
• 11.2. Market Challenges
• 11.3. Impact Analysis

12 MEDICAL POLYMER MARKET OPPORTUNITIES

13 MEDICAL POLYMER MARKET TRENDS

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY-SIDE ANALYSIS

• 15.1. Demand Side Analysis
• 15.2. Supply Side Analysis
  • 15.2.1. Top Product Launches
  • 15.2.2. Top Business Partnerships
  • 15.2.3. Top Business Expansions, Investments, and Divestitures
  • 15.2.4. Top Merger and Acquisitions

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

• 17.1. Porters Fiver Forces Analysis
  • 17.1.1. Bargaining Power of Buyer
  • 17.1.2. Bargaining Power of Supplier
  • 17.1.3. Intensity of Rivalry
  • 17.1.4. Threats of New Entrant
  • 17.1.5. Threat of Substitute
• 17.2. Company Share Analysis, by Revenue

18 COMPANY PROFILED

• 18.1. SABIC
• 18.2. BASF SE
• 18.3. Celanese Corporation
• 18.4. Evonik Industries AG
• 18.5. Solvay S.A.
• 18.6. Arkema S.A.
• 18.7. The Lubrizol Corporation
• 18.8. The Ensinger Group
• 18.9. Covestro AG
• 18.10. Victrex plc

19 DISCLAIMER